MONDAY, April 12, 2021 (HealthDay News) — Most people are familiar with common sun-protection advice, from wearing and reapplying sunscreen to putting on a hat. But a new Canadian study finds that for people who take certain blood pressure medications, that advice becomes even more critical because those drugs canContinue Reading
MONDAY, April 12, 2021 (HealthDay News) — People living with someone who has COVID-19 appear to get powerful protection against infection when they are given Regeneron’s antibody cocktail, a new study shows. The findings suggest that beyond preventing the worst outcomes for coronavirus infection when given early enough, the cocktailContinue Reading
MONDAY, April 12, 2021 (HealthDay News) — Once you’ve landed that coveted coronavirus vaccine appointment, you’ll likely have to fill out a form on your medical history and whether you’re allergic to any of the vaccine’s ingredients. But there could be another question waiting for you: Have you ever hadContinue Reading
MONDAY, April 12, 2021 (HealthDay News) — People with cancers of the blood, bone marrow or lymph nodes are at an increased risk of not making protective coronavirus antibodies after COVID-19 vaccination, a new study warns. The risk is particularly high for those with chronic lymphocytic leukemia (CLL). The researchersContinue Reading
MONDAY, April 12, 2021 (HealthDay News) — Older adults in long-term care develop detectible antibodies after COVID-19 vaccination, which may mean it’s safe to reopen these facilities, according to a new study. But because it’s unclear how long the antibodies last, researchers from University of Pittsburgh Medical Center (UPMC) sayContinue Reading
FRIDAY, April 9, 2021 (HealthDay News) — Doctors might have figured out why AstraZeneca’s COVID-19 vaccine may cause life-threatening blood clots in very rare cases. The discovery, made in a pair of reports published online Friday in the New England Journal of Medicine, could be key to the global rolloutContinue Reading
FRIDAY, April 9, 2021 (HealthDay News) — In a setback to a national vaccination campaign that was finally gaining ground, the federal government said Thursday that Johnson & Johnson will allocate 86 percent fewer doses of its coronavirus vaccine across the United States next week. The company delivered the firstContinue Reading
THURSDAY, April 8, 2021 (HealthDay News) — A new clinical trial will investigate whether people who are highly allergic or have what’s known as a mast cell disorder are at higher risk for a sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines. “The public understandably has been concernedContinue Reading
THURSDAY, April 8, 2021 (HealthDay News) — Two COVID-19 vaccines appear to work well against a rapidly spreading coronavirus variant that arose in California, but less effective against a variant that first emerged in South Africa, researchers report. “The good news is the California variant does not appear to beContinue Reading
WEDNESDAY, April 7, 2021 (HealthDay News) — Two people in the Johnson & Johnson COVID-19 vaccine trial developed Guillain-Barré syndrome, but it’s highly doubtful the vaccine is to blame, according to a just-published case study. Although both people were in the same trial, one was given the vaccine and theContinue Reading
WEDNESDAY, April 7, 2021 (HealthDay News) — Being jailed puts teens with untreated psychiatric disorders at increased risk for long-term mental health struggles, researchers say. “These are not necessarily bad kids, but they have many strikes against them,” said study lead author Linda Teplin. “Physical abuse, sexual abuse and neglectContinue Reading
WEDNESDAY, April 7, 2021 (HealthDay News) — In findings that bode well for the full reopening of schools across America, a new government survey shows that nearly 80 percent of school employees and child care workers have received at least one dose of a coronavirus vaccine. Released by the U.S.Continue Reading
WEDNESDAY, April 7, 2021 (HealthDay News) — Doctors are seeing such cases around the world: About a third of COVID-19 patients go on to develop “long-haul” neurological or psychiatric conditions months after being infected, new research shows. The findings suggest a link between COVID-19 and a higher risk for laterContinue Reading
TUESDAY, April 6, 2021 (HealthDay News) — There’s good news for the millions of Americans who’ve already received a dose or two of Moderna’s COVID-19 vaccine: New research shows the vaccine should protect against illness for at least six months. The new study tracked 33 participants in the trials thatContinue Reading